首页 > 最新文献

Journal of Clinical Medicine最新文献

英文 中文
Carcinoid Heart Disease: The Role of Echocardiography in Raising the First Suspicion. 类癌性心脏病:超声心动图在提出第一种怀疑中的作用。
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-05 DOI: 10.3390/jcm15051978
Silvia Stavagna, Giovanna Manzi, Danilo Angotti, Andrea D'Amato, Elisa Giannetta, Roberto Badagliacca, Federico Ciccarelli, Lucrezia Netti, Paolo Severino, Wael Saade, Carmine Dario Vizza, Viviana Maestrini

Neuroendocrine tumors (NETs) are rare neoplasms arising from the diffuse neuroendocrine system that can range from indolent to highly aggressive diseases. They usually clinically manifest when reaching a significant size or when hepatic metastases develop, leading to overproduction and impaired hepatic metabolism of vasoactive substances. The clinical course of NETs may be complicated by cardiac involvement, known as carcinoid heart disease (CHD), predominantly affecting the right side of the heart. CHD is characterized by specific echocardiographic features, including thickening, reduced excursion and retraction of valvular leaflets, resulting in valvular stenosis or regurgitation. Despite its clinical relevance, awareness of CHD as a complex hormonal sequela of NETs remains limited among cardiologists, and its echocardiographic findings are not universally recognized. This review aims to (a) provide cardiologists with the main principles for understanding CHD pathophysiology; (b) illustrate the main echocardiographic features of CHD, using a stepwise approach; and (c) refine a diagnostic algorithm for detecting cardiac involvement in NET populations and identifying patients at high risk of developing CHD.

神经内分泌肿瘤(NETs)是一种罕见的肿瘤,起源于弥漫性神经内分泌系统,其范围从惰性到高度侵袭性疾病。它们通常在达到显著大小或发生肝转移时表现出来,导致血管活性物质的过量产生和肝脏代谢受损。net的临床过程可能因心脏受累而复杂化,称为类癌性心脏病(CHD),主要影响心脏右侧。冠心病具有特定的超声心动图特征,包括瓣膜小叶增厚、减少偏移和收缩,导致瓣膜狭窄或反流。尽管具有临床意义,但心脏病专家对冠心病作为net的复杂激素后遗症的认识仍然有限,其超声心动图结果也未得到普遍认可。本综述旨在(a)为心脏科医生提供理解冠心病病理生理的主要原则;(b)采用逐步方法说明冠心病的主要超声心动图特征;(c)改进一种诊断算法,用于检测NET人群的心脏受累情况,并识别患冠心病的高风险患者。
{"title":"Carcinoid Heart Disease: The Role of Echocardiography in Raising the First Suspicion.","authors":"Silvia Stavagna, Giovanna Manzi, Danilo Angotti, Andrea D'Amato, Elisa Giannetta, Roberto Badagliacca, Federico Ciccarelli, Lucrezia Netti, Paolo Severino, Wael Saade, Carmine Dario Vizza, Viviana Maestrini","doi":"10.3390/jcm15051978","DOIUrl":"10.3390/jcm15051978","url":null,"abstract":"<p><p>Neuroendocrine tumors (NETs) are rare neoplasms arising from the diffuse neuroendocrine system that can range from indolent to highly aggressive diseases. They usually clinically manifest when reaching a significant size or when hepatic metastases develop, leading to overproduction and impaired hepatic metabolism of vasoactive substances. The clinical course of NETs may be complicated by cardiac involvement, known as carcinoid heart disease (CHD), predominantly affecting the right side of the heart. CHD is characterized by specific echocardiographic features, including thickening, reduced excursion and retraction of valvular leaflets, resulting in valvular stenosis or regurgitation. Despite its clinical relevance, awareness of CHD as a complex hormonal sequela of NETs remains limited among cardiologists, and its echocardiographic findings are not universally recognized. This review aims to (a) provide cardiologists with the main principles for understanding CHD pathophysiology; (b) illustrate the main echocardiographic features of CHD, using a stepwise approach; and (c) refine a diagnostic algorithm for detecting cardiac involvement in NET populations and identifying patients at high risk of developing CHD.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12986470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopy vs. Laparotomy for Management of Postpartum Complications-A Retrospective Cohort Study. 腹腔镜与剖腹手术治疗产后并发症的回顾性队列研究
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-05 DOI: 10.3390/jcm15051982
Liat Mor, Ohad Gluck, Amit Kreiner, Ram Kerner, Shimon Ginath, Ran Keidar, Ron Sagiv

Background: Postpartum complications requiring surgical intervention are challenging due to physiologic and anatomic changes. While laparotomy remains standard, laparoscopy is increasingly used. We compared outcomes of laparoscopic management of postpartum complications versus open management of postpartum complications. Methods: This retrospective cohort study included patients undergoing surgical intervention within three weeks postpartum at a single tertiary center between 2010 and 2023. Approach selection was primarily time-dependent, following an institutional practice change in 2020. Demographic, operative, and postoperative outcomes were compared. Results: Sixty-two participants with postpartum complications necessitating surgical intervention were included: 54 in the laparotomy group and 8 who underwent laparoscopy. Demographic characteristics were similar between groups. The main indication for laparoscopy was suspected uterine scar defects (p = 0.006), while laparotomy was obtained mainly in cases of suspected bleeding (p = 0.001). Both groups had comparable operative time, though the laparoscopy group had a shorter postoperative admission (p = 0.043). Conclusions: Laparoscopy is feasible for various postpartum complications. It offers comparable operative times to laparotomy with shorter postoperative admissions. Therefore, it is a promising alternative in selected cases when surgical expertise is available.

背景:由于生理和解剖的变化,需要手术干预的产后并发症具有挑战性。虽然剖腹手术仍然是标准的,但腹腔镜检查的应用越来越多。我们比较了腹腔镜下处理产后并发症与开放式处理产后并发症的结果。方法:本回顾性队列研究纳入2010年至2023年在单一三级中心产后三周内接受手术干预的患者。在2020年制度实践发生变化之后,方法选择主要依赖于时间。比较人口学、手术和术后结果。结果:有产后并发症需要手术干预的患者共62例,其中开腹组54例,腹腔镜组8例。组间人口统计学特征相似。怀疑子宫瘢痕缺损者以腹腔镜手术为主(p = 0.006),怀疑出血者以开腹手术为主(p = 0.001)。两组手术时间相当,但腹腔镜组术后住院时间较短(p = 0.043)。结论:腹腔镜手术治疗各种产后并发症是可行的。它提供了与剖腹手术相当的手术时间,术后住院时间更短。因此,这是一个很有前途的选择,在选定的情况下,当外科专业知识是可用的。
{"title":"Laparoscopy vs. Laparotomy for Management of Postpartum Complications-A Retrospective Cohort Study.","authors":"Liat Mor, Ohad Gluck, Amit Kreiner, Ram Kerner, Shimon Ginath, Ran Keidar, Ron Sagiv","doi":"10.3390/jcm15051982","DOIUrl":"10.3390/jcm15051982","url":null,"abstract":"<p><p><b>Background:</b> Postpartum complications requiring surgical intervention are challenging due to physiologic and anatomic changes. While laparotomy remains standard, laparoscopy is increasingly used. We compared outcomes of laparoscopic management of postpartum complications versus open management of postpartum complications. <b>Methods:</b> This retrospective cohort study included patients undergoing surgical intervention within three weeks postpartum at a single tertiary center between 2010 and 2023. Approach selection was primarily time-dependent, following an institutional practice change in 2020. Demographic, operative, and postoperative outcomes were compared. <b>Results:</b> Sixty-two participants with postpartum complications necessitating surgical intervention were included: 54 in the laparotomy group and 8 who underwent laparoscopy. Demographic characteristics were similar between groups. The main indication for laparoscopy was suspected uterine scar defects (<i>p</i> = 0.006), while laparotomy was obtained mainly in cases of suspected bleeding (<i>p</i> = 0.001). Both groups had comparable operative time, though the laparoscopy group had a shorter postoperative admission (<i>p</i> = 0.043). <b>Conclusions:</b> Laparoscopy is feasible for various postpartum complications. It offers comparable operative times to laparotomy with shorter postoperative admissions. Therefore, it is a promising alternative in selected cases when surgical expertise is available.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985969/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Posterior Reversible Encephalopathy Syndrome in Peritoneal Dialysis Patients: A Four-Case Series. 腹膜透析患者的后部可逆性脑病综合征:一个四例系列。
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-05 DOI: 10.3390/jcm15052003
Nanda Shajan, Gabrielė Mikšytė, Diana Sukackienė, Giedrė Žulpaitė, Raminta Lukšaitė-Lukštė, Laurynas Rimševičius, Marius Miglinas

Background/Objectives: Posterior reversible encephalopathy syndrome (PRES) is a neurological condition characterized by acute neurological symptoms and vasogenic edema, usually affecting the posterior circulation. It is described in end-stage renal disease (ESRD), but its presentation in peritoneal dialysis (PD) is not well defined. We aimed to describe the clinical, radiological, and dialysis-related features of PRES in PD patients and highlight factors relevant for diagnosis and management. Materials and Methods: We conducted a retrospective descriptive case series of four ESRD patients on PD or recently transitioned from PD to hemodialysis (HD) who developed PRES at a single center. Clinical data, laboratory results, dialysis characteristics, and neuroimaging findings were obtained from medical records. PRES was diagnosed based on acute neurological symptoms in the setting of severe hypertension and uremia, with CT and/or MRI findings supportive of PRES when present and exclusion of alternative diagnoses. Results: All patients presented with acute neurological manifestations, including headache, visual disturbances, seizures, and/or altered consciousness, in the context of marked hypertension and uremia. Neuroimaging findings ranged from normal CT/MRI to subtle bilateral occipital hypodensities and, in one case, extensive supra- and infratentorial vasogenic edema with internal hydrocephalus and subependymal edema. In three patients, inadequate volume or solute control on PD prompted temporary or permanent transition to HD to improve blood pressure and fluid management. With antihypertensive therapy, seizure control when required, correction of metabolic disturbances, and optimization of dialysis, all patients recovered clinically, with time to PRES resolution ranging from 7 to 43 days. Conclusions: PRES should be considered in PD patients with new-onset seizures, visual symptoms, or unexplained changes in mental status, particularly during hypertensive crises and uremia. Early CT/MRI, prompt blood pressure control, and careful adjustment of dialysis modality appear important for achieving favorable neurological outcomes.

背景/目的:后部可逆性脑病综合征(PRES)是一种以急性神经系统症状和血管源性水肿为特征的神经系统疾病,通常影响后循环。它在终末期肾病(ESRD)中有描述,但在腹膜透析(PD)中没有很好的定义。我们旨在描述PD患者PRES的临床、放射学和透析相关特征,并强调与诊断和治疗相关的因素。材料和方法:我们进行了一项回顾性描述性病例系列研究,研究对象为4名在单一中心患有PD或新近从PD过渡到血液透析(HD)的ESRD患者。临床资料、实验室结果、透析特征和神经影像学结果均来自医疗记录。PRES的诊断是基于严重高血压和尿毒症的急性神经系统症状,CT和/或MRI结果支持PRES的存在,并排除其他诊断。结果:所有患者均表现出急性神经系统症状,包括头痛、视觉障碍、癫痫发作和/或意识改变,伴有明显的高血压和尿毒症。神经影像学表现从正常的CT/MRI到轻微的双侧枕部低密度,在一个病例中,广泛的幕上和幕下血管源性水肿伴内部脑积水和室管膜下水肿。在3例患者中,PD的容量或溶质控制不足导致暂时或永久过渡到HD以改善血压和液体管理。通过降压治疗,必要时控制癫痫发作,纠正代谢紊乱,优化透析,所有患者临床恢复,PRES缓解时间从7天到43天不等。结论:出现新发癫痫、视觉症状或不明原因精神状态改变的PD患者,尤其是高血压危象和尿毒症患者,应考虑PRES。早期CT/MRI,及时控制血压,仔细调整透析方式对于获得良好的神经预后很重要。
{"title":"Posterior Reversible Encephalopathy Syndrome in Peritoneal Dialysis Patients: A Four-Case Series.","authors":"Nanda Shajan, Gabrielė Mikšytė, Diana Sukackienė, Giedrė Žulpaitė, Raminta Lukšaitė-Lukštė, Laurynas Rimševičius, Marius Miglinas","doi":"10.3390/jcm15052003","DOIUrl":"10.3390/jcm15052003","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Posterior reversible encephalopathy syndrome (PRES) is a neurological condition characterized by acute neurological symptoms and vasogenic edema, usually affecting the posterior circulation. It is described in end-stage renal disease (ESRD), but its presentation in peritoneal dialysis (PD) is not well defined. We aimed to describe the clinical, radiological, and dialysis-related features of PRES in PD patients and highlight factors relevant for diagnosis and management. <b>Materials and Methods:</b> We conducted a retrospective descriptive case series of four ESRD patients on PD or recently transitioned from PD to hemodialysis (HD) who developed PRES at a single center. Clinical data, laboratory results, dialysis characteristics, and neuroimaging findings were obtained from medical records. PRES was diagnosed based on acute neurological symptoms in the setting of severe hypertension and uremia, with CT and/or MRI findings supportive of PRES when present and exclusion of alternative diagnoses. <b>Results:</b> All patients presented with acute neurological manifestations, including headache, visual disturbances, seizures, and/or altered consciousness, in the context of marked hypertension and uremia. Neuroimaging findings ranged from normal CT/MRI to subtle bilateral occipital hypodensities and, in one case, extensive supra- and infratentorial vasogenic edema with internal hydrocephalus and subependymal edema. In three patients, inadequate volume or solute control on PD prompted temporary or permanent transition to HD to improve blood pressure and fluid management. With antihypertensive therapy, seizure control when required, correction of metabolic disturbances, and optimization of dialysis, all patients recovered clinically, with time to PRES resolution ranging from 7 to 43 days. <b>Conclusions:</b> PRES should be considered in PD patients with new-onset seizures, visual symptoms, or unexplained changes in mental status, particularly during hypertensive crises and uremia. Early CT/MRI, prompt blood pressure control, and careful adjustment of dialysis modality appear important for achieving favorable neurological outcomes.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985986/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Application of STRATOS for Restoration of Clavicular Stability After Oncologic Sternoclavicular Joint Resection: A Case Report and Review of the Literature. STRATOS在胸锁关节肿瘤切除术后锁骨稳定性恢复中的新应用:1例报告及文献复习。
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-05 DOI: 10.3390/jcm15052002
Shehab Mohamed, Luca Bertolaccini, Roberto Gasparri, Giorgio Lo Iacono, Antonio Mazzella, Monica Casiraghi, Claudia Bardoni, Cristina Diotti, Lorenzo Spaggiari

Background: Chondrosarcomas of the manubrium are exceedingly rare, accounting for approximately 20% of all primary bone malignancies, and present unique challenges in surgical management and reconstruction. Reliable reconstructive strategies for medial clavicular stabilization remain limited.

Case presentation: We report the first documented use of STRATOS bars for unilateral clavicular stabilization following manubrial chondrosarcoma resection. A 19-year-old woman with a poorly differentiated (G3) chondrosarcoma of the manubrium underwent neoadjuvant chemotherapy followed by en bloc resection of the manubrium, medial clavicle, and first rib. Reconstruction and clavicular stabilization were achieved using STRATOS, which is traditionally employed for chest-wall reconstruction. This represents a novel use of the device for medial clavicular stabilization after SCJ resection. At the 6-month follow-up, the patient remained disease-free, with preserved shoulder function and stable reconstruction. STRATOS provided stable fixation, preserved shoulder function, and an excellent cosmetic outcome. A brief review of the literature on sternal chondrosarcoma and reconstruction techniques is also presented.

Conclusion: This unique application expands the reconstructive possibilities of modular titanium systems. It may offer a more reliable biomechanical alternative to traditional fixation methods in cases requiring stability of the shoulder girdle after SCJ resection. Further validation through biomechanical studies and larger case series is warranted.

背景:骨柄软骨肉瘤极为罕见,约占所有原发性骨恶性肿瘤的20%,在手术治疗和重建方面具有独特的挑战。可靠的锁骨内侧固定重建策略仍然有限。病例介绍:我们报告了第一个有文献记载的使用STRATOS棒在手关节软骨肉瘤切除术后单侧锁骨稳定。一位19岁的女性,患有低分化(G3)软骨肉瘤,接受了新辅助化疗,随后进行了柄、锁骨内侧和第一肋骨的整体切除。使用STRATOS实现重建和锁骨稳定,STRATOS传统上用于胸壁重建。这代表了该装置在SCJ切除术后锁骨内侧稳定中的一种新应用。在6个月的随访中,患者保持无病状态,肩关节功能保留,重建稳定。STRATOS提供了稳定的固定,保留了肩关节功能和良好的美容效果。简要回顾文献胸骨软骨肉瘤和重建技术也提出。结论:这种独特的应用扩展了模块化钛系统重建的可能性。在SCJ切除术后需要肩带稳定性的病例中,它可能提供比传统固定方法更可靠的生物力学替代方法。通过生物力学研究和更大的病例系列进一步验证是必要的。
{"title":"Novel Application of STRATOS for Restoration of Clavicular Stability After Oncologic Sternoclavicular Joint Resection: A Case Report and Review of the Literature.","authors":"Shehab Mohamed, Luca Bertolaccini, Roberto Gasparri, Giorgio Lo Iacono, Antonio Mazzella, Monica Casiraghi, Claudia Bardoni, Cristina Diotti, Lorenzo Spaggiari","doi":"10.3390/jcm15052002","DOIUrl":"10.3390/jcm15052002","url":null,"abstract":"<p><strong>Background: </strong>Chondrosarcomas of the manubrium are exceedingly rare, accounting for approximately 20% of all primary bone malignancies, and present unique challenges in surgical management and reconstruction. Reliable reconstructive strategies for medial clavicular stabilization remain limited.</p><p><strong>Case presentation: </strong>We report the first documented use of STRATOS bars for unilateral clavicular stabilization following manubrial chondrosarcoma resection. A 19-year-old woman with a poorly differentiated (G3) chondrosarcoma of the manubrium underwent neoadjuvant chemotherapy followed by en bloc resection of the manubrium, medial clavicle, and first rib. Reconstruction and clavicular stabilization were achieved using STRATOS, which is traditionally employed for chest-wall reconstruction. This represents a novel use of the device for medial clavicular stabilization after SCJ resection. At the 6-month follow-up, the patient remained disease-free, with preserved shoulder function and stable reconstruction. STRATOS provided stable fixation, preserved shoulder function, and an excellent cosmetic outcome. A brief review of the literature on sternal chondrosarcoma and reconstruction techniques is also presented.</p><p><strong>Conclusion: </strong>This unique application expands the reconstructive possibilities of modular titanium systems. It may offer a more reliable biomechanical alternative to traditional fixation methods in cases requiring stability of the shoulder girdle after SCJ resection. Further validation through biomechanical studies and larger case series is warranted.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985845/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147458076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extended Criteria Donor Use in Heart Transplantation: A Promising Strategy to Expand the Donor Pool. 扩展标准供体在心脏移植中的使用:扩大供体池的一个有希望的策略。
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-05 DOI: 10.3390/jcm15051980
Giuseppe Fischetti, Lorenzo Giovannico, Domenico Parigino, Luca Savino, Federica Mazzone, Claudia Leo, Giuseppe Cristiano, Martina Macella, Paola De Santis, Federico Scalese, Eduardo Urgesi, Nicola Di Bari, Concetta Losito, Aldo Domenico Milano, Massimo Padalino, Massimiliano Carrozzini, Tomaso Bottio

Background: To address organ shortage and reduce waitlist mortality, the use of extended criteria donors (ECDs) in heart transplantation is increasing. Methods: We retrospectively analysed outcomes in 236 heart transplant recipients: 140 received standard donor (SD) hearts and 96 received ECD hearts. Results: No significant differences were found in early or mid-term survival between the SD and ECD groups with a 30-day mortality rates of 13% vs. 10% (p = 0.662) and estimated 1-year survival of 75% (95% CI: 62.3-78.3%) and 71% (95% CI: 55.3-76.2%) (p = 0.556), respectively. Mechanical ventilation prior to transplant (p < 0.001), ischemic time (p = 0.022), peripheral vascular disease (p = 0.011), and chronic obstructive pulmonary disease (p = 0.022) were the only independent predictors of mortality. Conclusions: In our cohort, heart transplantation using ECD was not associated with increased early or mid-term adverse events. This approach may help expand the donor pool without compromising post-transplant outcomes.

背景:为了解决器官短缺和减少等候名单死亡率,在心脏移植中使用扩展标准供体(ECDs)的情况正在增加。方法:我们回顾性分析236例心脏移植受者的结果:140例接受标准供体(SD)心脏,96例接受ECD心脏。结果:SD组和ECD组的早期或中期生存率无显著差异,30天死亡率分别为13%和10% (p = 0.662),估计1年生存率分别为75% (95% CI: 62.3-78.3%)和71% (95% CI: 55.3-76.2%) (p = 0.556)。移植前机械通气(p < 0.001)、缺血时间(p = 0.022)、外周血管疾病(p = 0.011)和慢性阻塞性肺疾病(p = 0.022)是死亡率的唯一独立预测因素。结论:在我们的队列中,采用ECD的心脏移植与早期或中期不良事件的增加无关。这种方法可能有助于扩大供体池,而不会影响移植后的结果。
{"title":"Extended Criteria Donor Use in Heart Transplantation: A Promising Strategy to Expand the Donor Pool.","authors":"Giuseppe Fischetti, Lorenzo Giovannico, Domenico Parigino, Luca Savino, Federica Mazzone, Claudia Leo, Giuseppe Cristiano, Martina Macella, Paola De Santis, Federico Scalese, Eduardo Urgesi, Nicola Di Bari, Concetta Losito, Aldo Domenico Milano, Massimo Padalino, Massimiliano Carrozzini, Tomaso Bottio","doi":"10.3390/jcm15051980","DOIUrl":"10.3390/jcm15051980","url":null,"abstract":"<p><p><b>Background</b>: To address organ shortage and reduce waitlist mortality, the use of extended criteria donors (ECDs) in heart transplantation is increasing. <b>Methods</b>: We retrospectively analysed outcomes in 236 heart transplant recipients: 140 received standard donor (SD) hearts and 96 received ECD hearts. <b>Results</b>: No significant differences were found in early or mid-term survival between the SD and ECD groups with a 30-day mortality rates of 13% vs. 10% (<i>p</i> = 0.662) and estimated 1-year survival of 75% (95% CI: 62.3-78.3%) and 71% (95% CI: 55.3-76.2%) (<i>p</i> = 0.556), respectively. Mechanical ventilation prior to transplant (<i>p</i> < 0.001), ischemic time (<i>p</i> = 0.022), peripheral vascular disease (<i>p</i> = 0.011), and chronic obstructive pulmonary disease (<i>p</i> = 0.022) were the only independent predictors of mortality. <b>Conclusions</b>: In our cohort, heart transplantation using ECD was not associated with increased early or mid-term adverse events. This approach may help expand the donor pool without compromising post-transplant outcomes.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative Use of a Topical Anesthetic Gel Versus Balanced Salt Solution During Cataract Surgery: Effects on Corneal Structure and Ocular Surface. 白内障手术中使用表面麻醉凝胶与平衡盐溶液:对角膜结构和眼表的影响。
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-05 DOI: 10.3390/jcm15051992
Pier Giuseppe Ruggeri, Alberto Carnicci, Matilde Buzzi, Fabrizio Giansanti, Rita Mencucci

Background/Objectives: During cataract surgery, topical anesthesia is routinely achieved through the instillation of topical anesthetic eye drops, while different agents may be applied to the corneal surface during the procedure to support lubrication and protection. The impact of these intraoperative strategies on corneal integrity and postoperative ocular surface recovery remains an area of clinical interest. This study aimed to compare the intraoperative and postoperative effects of applying a topical anesthetic gel (Ophtesic, Horus Pharma) on the corneal surface versus the use of balanced salt solution (BSS) during cataract surgery. Methods: In this longitudinal, observational prospective study, 24 eyes of 24 patients undergoing phacoemulsification received either topical anesthetic gel (n = 15) or BSS irrigation (n = 9). Central corneal thickness (CCT) and epithelial thickness were measured preoperatively and on postoperative days 1, 5, and 15 using anterior segment optical coherence tomography (AS-OCT). Basal epithelial cell (BEC) density was assessed by in vivo confocal microscopy (IVCM), while OSDI score, non-invasive breakup time (NI-BUT), and Schirmer test I values were evaluated preoperatively and on postoperative days 5 and 15. Patient and surgeon satisfaction were rated using a Likert-like scale. Results: Both groups showed increased CCT and epithelial thickness at day 1. In the gel group, CCT returned to baseline by day 15 (p = 0.361), and epithelial thickness normalized by day 5 (p = 0.066). In the BSS group, CCT remained elevated at day 15 (p < 0.05), and epithelial thickness decreased at day 5 (p < 0.05) before returning to baseline. BEC density normalized at day 15 in the gel group (p = 0.107) but remained altered in the BSS group (p < 0.05). NI-BUT Schirmer I, and OSDI showed a trend toward faster recovery in the gel group than in the BSS group. Conclusions: In this exploratory study, intraoperative application of a topical anesthetic gel appeared to support early normalization of corneal and tear film parameters while providing effective anesthesia. Further studies are warranted to confirm these observations and evaluate potential long-term benefits.

背景/目的:在白内障手术中,表面麻醉通常是通过滴入表面麻醉滴眼液来实现的,而在手术过程中,可能会在角膜表面使用不同的药物来支持润滑和保护。这些术中策略对角膜完整性和术后眼表恢复的影响仍然是临床感兴趣的领域。本研究旨在比较白内障手术中在角膜表面应用表面麻醉凝胶(Ophtesic, Horus Pharma)与使用平衡盐溶液(BSS)的术中和术后效果。方法:在这项纵向、观察性的前瞻性研究中,24例超声乳化术患者的24只眼接受了表面麻醉凝胶(n = 15)或BSS冲洗(n = 9)。术前和术后第1、5、15天使用前段光学相干断层扫描(AS-OCT)测量角膜中央厚度(CCT)和上皮厚度。采用体内共聚焦显微镜(IVCM)评估基底上皮细胞(BEC)密度,术前、术后第5、15天评估OSDI评分、非侵入性破裂时间(ni -但)和Schirmer test I值。采用李克特量表对患者和外科医生的满意度进行评定。结果:两组在第1天CCT和上皮厚度均增加。在凝胶组,CCT在第15天恢复到基线(p = 0.361),上皮厚度在第5天正常化(p = 0.066)。在BSS组,CCT在第15天保持升高(p < 0.05),上皮厚度在第5天下降(p < 0.05),然后恢复到基线水平。凝胶组的BEC密度在第15天恢复正常(p = 0.107),而BSS组的BEC密度保持不变(p < 0.05)。与BSS组相比,凝胶组的ni -但Schirmer I和OSDI均有较快恢复的趋势。结论:在这项探索性研究中,术中应用表面麻醉凝胶似乎可以在提供有效麻醉的同时支持角膜和泪膜参数的早期正常化。需要进一步的研究来证实这些观察结果并评估潜在的长期益处。
{"title":"Intraoperative Use of a Topical Anesthetic Gel Versus Balanced Salt Solution During Cataract Surgery: Effects on Corneal Structure and Ocular Surface.","authors":"Pier Giuseppe Ruggeri, Alberto Carnicci, Matilde Buzzi, Fabrizio Giansanti, Rita Mencucci","doi":"10.3390/jcm15051992","DOIUrl":"10.3390/jcm15051992","url":null,"abstract":"<p><p><b>Background/Objectives:</b> During cataract surgery, topical anesthesia is routinely achieved through the instillation of topical anesthetic eye drops, while different agents may be applied to the corneal surface during the procedure to support lubrication and protection. The impact of these intraoperative strategies on corneal integrity and postoperative ocular surface recovery remains an area of clinical interest. This study aimed to compare the intraoperative and postoperative effects of applying a topical anesthetic gel (Ophtesic, Horus Pharma) on the corneal surface versus the use of balanced salt solution (BSS) during cataract surgery. <b>Methods:</b> In this longitudinal, observational prospective study, 24 eyes of 24 patients undergoing phacoemulsification received either topical anesthetic gel (n = 15) or BSS irrigation (n = 9). Central corneal thickness (CCT) and epithelial thickness were measured preoperatively and on postoperative days 1, 5, and 15 using anterior segment optical coherence tomography (AS-OCT). Basal epithelial cell (BEC) density was assessed by in vivo confocal microscopy (IVCM), while OSDI score, non-invasive breakup time (NI-BUT), and Schirmer test I values were evaluated preoperatively and on postoperative days 5 and 15. Patient and surgeon satisfaction were rated using a Likert-like scale. <b>Results:</b> Both groups showed increased CCT and epithelial thickness at day 1. In the gel group, CCT returned to baseline by day 15 (<i>p</i> = 0.361), and epithelial thickness normalized by day 5 (<i>p</i> = 0.066). In the BSS group, CCT remained elevated at day 15 (<i>p</i> < 0.05), and epithelial thickness decreased at day 5 (<i>p</i> < 0.05) before returning to baseline. BEC density normalized at day 15 in the gel group (<i>p</i> = 0.107) but remained altered in the BSS group (<i>p</i> < 0.05). NI-BUT Schirmer I, and OSDI showed a trend toward faster recovery in the gel group than in the BSS group. <b>Conclusions:</b> In this exploratory study, intraoperative application of a topical anesthetic gel appeared to support early normalization of corneal and tear film parameters while providing effective anesthesia. Further studies are warranted to confirm these observations and evaluate potential long-term benefits.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985571/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex-Specific Differences in Nutritional Status and Olfaction in Association with Cognitive Impairment Amongst Older Adults with Long COVID Syndrome. 老年长冠状病毒综合征患者营养状况和嗅觉的性别差异与认知障碍相关
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-05 DOI: 10.3390/jcm15051994
Alma L Guzmán-Gurrola, Laura González-López, Jonathan S Chávez-Íñiguez, Mariana Verduzco Vázquez, Efraín I Flores-Hernández, José A Novoa-Burquez, Maria G Zavala-Cerna

Background/Objectives: Long COVID has emerged as a significant public health concern, characterized by persistent symptoms following SARS-CoV-2 infection. Cognitive impairment is a common sequela, particularly among older adults (OAs). Although olfactory dysfunction and malnutrition have been previously associated with cognitive decline, it remains elusive to what extent sex-specific variations in these and additional factors will be pivotal to guiding targeted interventions in a sex-specific manner. To fill this gap in knowledge, we undertook a study with the purpose of investigating the contribution of sex-specific risk factors to the development of cognitive impairment (CI) in a cohort of OAs hospitalized with long COVID. Methods: We undertook a cross-sectional study among OAs hospitalized at a geriatric care unit. Olfactory function was assessed using the Sniffin' Stick Test. Cognitive impairment was evaluated by the Mini-Mental State Examination, and nutritional status was assessed with the Mini Nutritional Assessment (MNA). Statistical analyses included linear regression. Results: A total of 45 patients with long COVID were included, of whom 51% were female. The prevalence of CI was lower in men compared to women. In the single variable analysis, nutritional factors were associated with CI only in women; importantly, the loss of olfactory function was associated with CI in the whole group and to CI in women after multivariate analysis. Conclusions: Olfactory dysfunction is a potential biomarker for cognitive impairment in OAs with long COVID in a sex-specific manner. In our study nutritional status and probable obesity could be additional factors associated with CI; nevertheless, this was not confirmed in our multivariate analysis; therefore, this hypothesis would need to be tested in larger studies.

背景/目的:长冠状病毒已成为一个重大的公共卫生问题,其特征是SARS-CoV-2感染后持续出现症状。认知障碍是常见的后遗症,特别是在老年人(oa)中。虽然嗅觉功能障碍和营养不良以前与认知能力下降有关,但这些和其他因素的性别特异性差异在多大程度上对指导以性别特异性方式进行有针对性的干预至关重要,仍然是难以捉摸的。为了填补这一知识空白,我们开展了一项研究,目的是调查性别特异性危险因素对长期COVID住院的oa队列中认知功能障碍(CI)发展的贡献。方法:我们对在老年护理单位住院的oa进行了横断面研究。使用嗅探棒试验评估嗅觉功能。采用Mini- mental State Examination评估认知功能障碍,采用Mini- nutrition Assessment (MNA)评估营养状况。统计分析包括线性回归。结果:共纳入45例长冠肺炎患者,其中女性占51%。男性CI患病率低于女性。在单变量分析中,营养因素仅与女性CI相关;重要的是,在多变量分析后,嗅觉功能的丧失与整个组的CI和女性的CI相关。结论:嗅觉功能障碍是长冠状病毒OAs患者认知功能障碍的潜在生物标志物,具有性别特异性。在我们的研究中,营养状况和可能的肥胖可能是与CI相关的其他因素;然而,这在我们的多变量分析中没有得到证实;因此,这一假设需要在更大规模的研究中进行检验。
{"title":"Sex-Specific Differences in Nutritional Status and Olfaction in Association with Cognitive Impairment Amongst Older Adults with Long COVID Syndrome.","authors":"Alma L Guzmán-Gurrola, Laura González-López, Jonathan S Chávez-Íñiguez, Mariana Verduzco Vázquez, Efraín I Flores-Hernández, José A Novoa-Burquez, Maria G Zavala-Cerna","doi":"10.3390/jcm15051994","DOIUrl":"10.3390/jcm15051994","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Long COVID has emerged as a significant public health concern, characterized by persistent symptoms following SARS-CoV-2 infection. Cognitive impairment is a common sequela, particularly among older adults (OAs). Although olfactory dysfunction and malnutrition have been previously associated with cognitive decline, it remains elusive to what extent sex-specific variations in these and additional factors will be pivotal to guiding targeted interventions in a sex-specific manner. To fill this gap in knowledge, we undertook a study with the purpose of investigating the contribution of sex-specific risk factors to the development of cognitive impairment (CI) in a cohort of OAs hospitalized with long COVID. <b>Methods</b>: We undertook a cross-sectional study among OAs hospitalized at a geriatric care unit. Olfactory function was assessed using the Sniffin' Stick Test. Cognitive impairment was evaluated by the Mini-Mental State Examination, and nutritional status was assessed with the Mini Nutritional Assessment (MNA). Statistical analyses included linear regression. <b>Results</b>: A total of 45 patients with long COVID were included, of whom 51% were female. The prevalence of CI was lower in men compared to women. In the single variable analysis, nutritional factors were associated with CI only in women; importantly, the loss of olfactory function was associated with CI in the whole group and to CI in women after multivariate analysis. <b>Conclusions</b>: Olfactory dysfunction is a potential biomarker for cognitive impairment in OAs with long COVID in a sex-specific manner. In our study nutritional status and probable obesity could be additional factors associated with CI; nevertheless, this was not confirmed in our multivariate analysis; therefore, this hypothesis would need to be tested in larger studies.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985874/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147458046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Human Serum Albumin in Critically Ill Patients: A Narrative Review. 人血清白蛋白在危重病人中的应用:综述。
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-05 DOI: 10.3390/jcm15051981
Iñigo Rubio-Baines, Luigi Camporota, Duilio González-Delgado, Gemma Echarri, Maria Carmen Sala-Trull, Pablo Montero-López, Marc Vives

Background: Human serum albumin (HSA), the most abundant plasma protein, is essential for oncotic pressure, endothelial protection, drug binding, and immune modulation. Despite its widespread clinical use since the 1940s, its therapeutic benefit in critically ill patients remains debated. This narrative review summarizes current evidence on HSA use in common intensive care scenarios. Clinical Applications: In hepatorenal syndrome (HRS), albumin combined with vasoconstrictors like terlipressin improves renal function and survival. In spontaneous bacterial peritonitis (SBP), albumin lowers the risk of acute kidney injury and mortality, particularly in high-risk cirrhotic patients. Post-paracentesis albumin reduces circulatory dysfunction and may enhance survival in cirrhosis. For septic shock, trials show no overall mortality benefit over crystalloids, though albumin may offer hemodynamic advantages in specific subgroups. In acute respiratory distress syndrome (ARDS), albumin improves oxygenation in hypoalbuminemic patients, without survival benefits. During major cardiac or abdominal surgery, albumin reduces fluid needs and postoperative complications, especially in hypoalbuminemic individuals. In acute brain injury, albumin's role is controversial: it may aid recovery after cerebral hemorrhage, but can worsen outcomes in traumatic brain injury. In trauma and ECMO patients, albumin may stabilize hemodynamics and improve outcomes in selected cases. Conclusions: Inappropriate albumin use remains common, and evidence on its optimal concentration, dose, timing, and patient selection is limited. HSA is safe and beneficial in specific situations. Routine use should follow evidence-based guidelines. Future research must identify patients who are most likely to benefit and clarify optimal dosing strategies, concentrations, and therapeutic goals.

背景:人血清白蛋白(HSA)是最丰富的血浆蛋白,对肿瘤压力、内皮保护、药物结合和免疫调节至关重要。尽管自20世纪40年代以来广泛应用于临床,但其对危重患者的治疗效果仍存在争议。这篇叙述性综述总结了目前在常见重症监护情况下使用HSA的证据。临床应用:在肝肾综合征(HRS)中,白蛋白联合血管收缩剂如特利加压素可改善肾功能和生存率。在自发性细菌性腹膜炎(SBP)中,白蛋白可降低急性肾损伤和死亡率的风险,特别是在高危的肝硬化患者中。穿刺后白蛋白可减少循环功能障碍,并可提高肝硬化患者的生存率。对于感染性休克,尽管白蛋白可能在特定亚群中具有血流动力学优势,但试验显示晶体药物在总体死亡率上没有优势。在急性呼吸窘迫综合征(ARDS)中,白蛋白改善低白蛋白血症患者的氧合,但没有生存益处。在重大心脏或腹部手术中,白蛋白可减少液体需求和术后并发症,特别是在低白蛋白血症患者中。在急性脑损伤中,白蛋白的作用是有争议的:它可能有助于脑出血后的恢复,但可能使创伤性脑损伤的结果恶化。在创伤和ECMO患者中,白蛋白可以稳定血液动力学并改善某些病例的预后。结论:不适当的白蛋白使用仍然很常见,关于其最佳浓度、剂量、时间和患者选择的证据有限。HSA在特定情况下是安全有益的。常规使用应遵循循证指南。未来的研究必须确定最有可能受益的患者,并明确最佳剂量策略、浓度和治疗目标。
{"title":"Use of Human Serum Albumin in Critically Ill Patients: A Narrative Review.","authors":"Iñigo Rubio-Baines, Luigi Camporota, Duilio González-Delgado, Gemma Echarri, Maria Carmen Sala-Trull, Pablo Montero-López, Marc Vives","doi":"10.3390/jcm15051981","DOIUrl":"10.3390/jcm15051981","url":null,"abstract":"<p><p><b>Background</b>: Human serum albumin (HSA), the most abundant plasma protein, is essential for oncotic pressure, endothelial protection, drug binding, and immune modulation. Despite its widespread clinical use since the 1940s, its therapeutic benefit in critically ill patients remains debated. This narrative review summarizes current evidence on HSA use in common intensive care scenarios. <b>Clinical Applications</b>: In hepatorenal syndrome (HRS), albumin combined with vasoconstrictors like terlipressin improves renal function and survival. In spontaneous bacterial peritonitis (SBP), albumin lowers the risk of acute kidney injury and mortality, particularly in high-risk cirrhotic patients. Post-paracentesis albumin reduces circulatory dysfunction and may enhance survival in cirrhosis. For septic shock, trials show no overall mortality benefit over crystalloids, though albumin may offer hemodynamic advantages in specific subgroups. In acute respiratory distress syndrome (ARDS), albumin improves oxygenation in hypoalbuminemic patients, without survival benefits. During major cardiac or abdominal surgery, albumin reduces fluid needs and postoperative complications, especially in hypoalbuminemic individuals. In acute brain injury, albumin's role is controversial: it may aid recovery after cerebral hemorrhage, but can worsen outcomes in traumatic brain injury. In trauma and ECMO patients, albumin may stabilize hemodynamics and improve outcomes in selected cases. <b>Conclusions</b>: Inappropriate albumin use remains common, and evidence on its optimal concentration, dose, timing, and patient selection is limited. HSA is safe and beneficial in specific situations. Routine use should follow evidence-based guidelines. Future research must identify patients who are most likely to benefit and clarify optimal dosing strategies, concentrations, and therapeutic goals.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12986204/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147458064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-Transplant Sepsis After Liver Transplantation: Clinical Characteristics and Therapeutic Challenges. 肝移植后脓毒症:临床特点和治疗挑战。
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-05 DOI: 10.3390/jcm15051989
Vanja Silić, Nikolina Bašic-Jukić, Ivan Romić, Igor Petrović, Daniela Bandić Pavlović, Goran Pavlek, Emil Kinda

Background: Sepsis is one of the leading causes of early death after a liver transplant, with a frequency of up to 45% and a high death rate of 50% in more severe forms. Standard diagnostic and therapeutic algorithms are often not applicable to this specific population, where immunosuppression, reperfusion injury, and systemic inflammation overlap and generate a clinical picture that is significantly different from sepsis in immunocompetent patients. Methods: This paper analyzes the available literature and clinical experiences of characteristic immune and hemodynamic profiles of sepsis after liver transplants. Biomarkers (IL-6, IL-10, HLA-DR, lactate, and IgM) are discussed as tools for assessing immune status and guiding timely interventions, including the early application of continuous renal replacement therapy (CRRT) and the selective use of IgM-enriched immunoglobulins. Results: Sepsis after liver transplantation frequently unfolds in two phases, an initial hyper-inflammatory response driven by cytokine release and reperfusion injury and a second phase of secondary immunoparalysis characterized by reduced HLA-DR expression and increased anti-inflammatory signaling. The immunometabolic shift appears to influence the clinical course and may inform therapeutic decision-making. The immunoparalysis phase is accompanied by mitochondrial dysfunction and impaired vascular reactivity. This type of mechanism contributes to hemodynamic instability and a reduced response to standard therapy. Individualized monitoring and early use of hemofiltration and immunomodulatory measures can improve results in carefully selected patients. Conclusions: In this setting, an individualized immunometabolic approach may complement standard sepsis management in liver transplant recipients. The introduction of biomarkers of immune function into routine practice and the recognition of early signs of exhaustion of the immune response can assist in timely therapeutic decision-making and improve survival.

背景:脓毒症是肝移植术后早期死亡的主要原因之一,发生率高达45%,严重形式的死亡率高达50%。标准的诊断和治疗算法往往不适用于这一特定人群,免疫抑制、再灌注损伤和全身炎症重叠,产生的临床症状与免疫功能正常患者的败血症明显不同。方法:对肝移植术后脓毒症的免疫及血流动力学特征进行文献分析和临床经验分析。生物标志物(IL-6, IL-10, HLA-DR,乳酸和IgM)作为评估免疫状态和指导及时干预的工具进行了讨论,包括早期应用持续肾替代疗法(CRRT)和选择性使用富含IgM的免疫球蛋白。结果:肝移植后脓毒症通常分为两个阶段,一是由细胞因子释放和再灌注损伤驱动的初始高炎症反应,二是以HLA-DR表达降低和抗炎信号增加为特征的继发性免疫麻痹。免疫代谢变化似乎影响临床病程,并可能为治疗决策提供信息。免疫麻痹期伴有线粒体功能障碍和血管反应性受损。这种类型的机制导致血流动力学不稳定和降低对标准治疗的反应。个体化监测和早期使用血液过滤和免疫调节措施可以改善精心挑选的患者的结果。结论:在这种情况下,个体化免疫代谢方法可以补充肝移植受者的标准脓毒症管理。将免疫功能的生物标志物引入常规实践和识别免疫反应衰竭的早期迹象可以帮助及时做出治疗决策并提高生存率。
{"title":"Post-Transplant Sepsis After Liver Transplantation: Clinical Characteristics and Therapeutic Challenges.","authors":"Vanja Silić, Nikolina Bašic-Jukić, Ivan Romić, Igor Petrović, Daniela Bandić Pavlović, Goran Pavlek, Emil Kinda","doi":"10.3390/jcm15051989","DOIUrl":"10.3390/jcm15051989","url":null,"abstract":"<p><p><b>Background:</b> Sepsis is one of the leading causes of early death after a liver transplant, with a frequency of up to 45% and a high death rate of 50% in more severe forms. Standard diagnostic and therapeutic algorithms are often not applicable to this specific population, where immunosuppression, reperfusion injury, and systemic inflammation overlap and generate a clinical picture that is significantly different from sepsis in immunocompetent patients. <b>Methods:</b> This paper analyzes the available literature and clinical experiences of characteristic immune and hemodynamic profiles of sepsis after liver transplants. Biomarkers (IL-6, IL-10, HLA-DR, lactate, and IgM) are discussed as tools for assessing immune status and guiding timely interventions, including the early application of continuous renal replacement therapy (CRRT) and the selective use of IgM-enriched immunoglobulins. <b>Results:</b> Sepsis after liver transplantation frequently unfolds in two phases, an initial hyper-inflammatory response driven by cytokine release and reperfusion injury and a second phase of secondary immunoparalysis characterized by reduced HLA-DR expression and increased anti-inflammatory signaling. The immunometabolic shift appears to influence the clinical course and may inform therapeutic decision-making. The immunoparalysis phase is accompanied by mitochondrial dysfunction and impaired vascular reactivity. This type of mechanism contributes to hemodynamic instability and a reduced response to standard therapy. Individualized monitoring and early use of hemofiltration and immunomodulatory measures can improve results in carefully selected patients. <b>Conclusions:</b> In this setting, an individualized immunometabolic approach may complement standard sepsis management in liver transplant recipients. The introduction of biomarkers of immune function into routine practice and the recognition of early signs of exhaustion of the immune response can assist in timely therapeutic decision-making and improve survival.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985828/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Magnesium-Modified Titanium Implants on Osseointegration: A Systematic Review and Meta-Analysis of Preclinical Studies. 镁改性钛种植体对骨整合的影响:临床前研究的系统回顾和荟萃分析。
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-05 DOI: 10.3390/jcm15051987
Ali Alenezi, Dhafer Alasmari

Objectives: This study systematically evaluated and quantitatively synthesized preclinical evidence on the effects of magnesium (Mg) incorporation into or coating of titanium dental implants on osseointegration and peri-implant bone formation. Methods: Electronic searches of PubMed, Scopus, and Web of Science were performed up to May 2025 to identify animal studies evaluating Mg-modified titanium implants. Eligible studies compared Mg-incorporated or Mg-coated implants with non-modified titanium controls and reported quantitative histomorphometric outcomes. Primary outcomes included the values of bone-to-implant contact (BIC) and bone area (BA) around implants. Study quality was assessed using the ARRIVE 2.0 guidelines. Meta-analyses were performed using weighted mean differences with 95% confidence intervals under fixed- or random-effects models based on heterogeneity. Results: Eleven preclinical animal studies conducted in rabbit and rat models were included. Mg was incorporated using various surface-modification techniques, including ion implantation, Mg-substituted hydroxyapatite coatings, mesoporous titania layers, and nanotubular structures. Overall, the studies' quality was high, with most studies rated as excellent and with a low-to-moderate risk of bias. Furthermore, the meta-analysis revealed a significant increase in BIC for Mg-modified implants compared with uncoated implants (Z = 4.38, p < 0.001), implying improved osseointegration. Meanwhile, pooled BA values showed no significant differences between the groups (Z = 0.93, p = 0.35). Conclusions: Mg coating onto or incorporation into titanium implant surfaces can improve BIC in preclinical models, indicating improved osseointegration in the early stages.

目的:系统评价和定量合成钛牙种植体中掺入或涂覆镁对骨整合和种植体周围骨形成影响的临床前证据。方法:截至2025年5月,对PubMed、Scopus和Web of Science进行电子检索,以确定评估mg修饰钛植入物的动物研究。符合条件的研究比较了含镁或包覆镁植入物与未修饰的钛对照物,并报告了定量组织形态学结果。主要结果包括骨与种植体接触(BIC)和种植体周围骨面积(BA)的值。使用ARRIVE 2.0指南评估研究质量。在基于异质性的固定效应或随机效应模型下,采用加权平均差异和95%置信区间进行meta分析。结果:纳入11项兔、大鼠临床前动物实验。镁通过各种表面修饰技术被掺入,包括离子注入、镁取代羟基磷灰石涂层、介孔二氧化钛层和纳米管结构。总体而言,这些研究的质量很高,大多数研究被评为优秀,偏倚风险为低至中等。此外,荟萃分析显示,与未涂覆种植体相比,mg修饰种植体的BIC显著增加(Z = 4.38, p < 0.001),这意味着骨整合得到改善。合并BA值组间差异无统计学意义(Z = 0.93, p = 0.35)。结论:在临床前模型中,钛种植体表面涂覆或掺入Mg可以改善BIC,表明早期骨整合得到改善。
{"title":"Effect of Magnesium-Modified Titanium Implants on Osseointegration: A Systematic Review and Meta-Analysis of Preclinical Studies.","authors":"Ali Alenezi, Dhafer Alasmari","doi":"10.3390/jcm15051987","DOIUrl":"10.3390/jcm15051987","url":null,"abstract":"<p><p><b>Objectives</b>: This study systematically evaluated and quantitatively synthesized preclinical evidence on the effects of magnesium (Mg) incorporation into or coating of titanium dental implants on osseointegration and peri-implant bone formation. <b>Methods</b>: Electronic searches of PubMed, Scopus, and Web of Science were performed up to May 2025 to identify animal studies evaluating Mg-modified titanium implants. Eligible studies compared Mg-incorporated or Mg-coated implants with non-modified titanium controls and reported quantitative histomorphometric outcomes. Primary outcomes included the values of bone-to-implant contact (BIC) and bone area (BA) around implants. Study quality was assessed using the ARRIVE 2.0 guidelines. Meta-analyses were performed using weighted mean differences with 95% confidence intervals under fixed- or random-effects models based on heterogeneity. <b>Results</b>: Eleven preclinical animal studies conducted in rabbit and rat models were included. Mg was incorporated using various surface-modification techniques, including ion implantation, Mg-substituted hydroxyapatite coatings, mesoporous titania layers, and nanotubular structures. Overall, the studies' quality was high, with most studies rated as excellent and with a low-to-moderate risk of bias. Furthermore, the meta-analysis revealed a significant increase in BIC for Mg-modified implants compared with uncoated implants (Z = 4.38, <i>p</i> < 0.001), implying improved osseointegration. Meanwhile, pooled BA values showed no significant differences between the groups (Z = 0.93, <i>p</i> = 0.35). <b>Conclusions</b>: Mg coating onto or incorporation into titanium implant surfaces can improve BIC in preclinical models, indicating improved osseointegration in the early stages.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12986129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1